List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Diabetic Peripheral Neuropathy Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Diabetic Peripheral Neuropathy
Apr 18, 2019: Robust analgesic activity of Aptinyx’s NYX-2925 in advanced DPN patients revealed through further analysis of data from phase 2 study
Mar 28, 2019: Aptinyx to present detailed results from phase 2 painful DPN study of NYX-2925 at American Pain Society Scientific Meeting
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Region, 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, North America, Top Countries, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019*
Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Phase, 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
Diabetic Peripheral Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Region (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019*
Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Phase (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
Diabetic Peripheral Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
GlobalData Methodology

Companies Mentioned
- Pfizer Inc
- Eli Lilly and Co
- Astellas Pharma Inc
- Syneos Health Inc
- Grunenthal GmbH
- Nestle Health Science SA
- Winsantor Inc
- Johnson & Johnson
- Diablo Clinical Research Inc
- Assertio Therapeutics Inc